How Much Did BioAssay Systems Raise?
Funding & Key Investors

BioAssay Systems has solidified its market position through a series of strategic capital injections, culminating in a total funding accumulation of $359K. The firm recently secured a major strategic investment of $209K, marking a significant milestone in its late-stage growth trajectory. This influx of capital underscores the company's resilience and its critical role in the global life sciences infrastructure, providing the necessary liquidity to scale operations and expand its high-throughput assay portfolio.

What is BioAssay Systems?

BioAssay Systems
Business ServicesResearch & DevelopmentManufacturing

BioAssay Systems operates at the intersection of biotechnology and analytical chemistry, specializing in the development and manufacturing of high-throughput assay solutions. With a robust catalog exceeding 250 specialized kits, the company serves as a vital partner for biopharmaceutical enterprises and academic research institutions engaged in complex drug discovery workflows. By prioritizing user-friendly designs that minimize the need for extensive optimization, BioAssay Systems has successfully lowered the barrier to entry for sophisticated analytical testing. Their service model, which encompasses bespoke assay customization and lead discovery support, positions them as a high-value provider in a competitive global market, characterized by a commitment to technical precision and cost-effective laboratory solutions.

How much funding has BioAssay Systems raised?

BioAssay Systems has raised a total of $359K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$209K

Debt (2020): $150K with participation from PPP

Debt (2021): $209K led by PPP

Key Investors in BioAssay Systems

PPP

Public-Private Partnership

Undisclosed Investors

Undisclosed Investors

Undisclosed Investors

Undisclosed Investors

What's next for BioAssay Systems?

With the recent infusion of $209K, BioAssay Systems is well-positioned to accelerate its research and development initiatives, particularly in the realm of automated drug discovery platforms. The company is expected to leverage this capital to enhance its manufacturing capabilities, ensuring that its supply chain can meet the increasing demand from global biopharmaceutical partners. Furthermore, the strategic focus will likely shift toward expanding its footprint in emerging markets and deepening its analytical service offerings. By maintaining its reputation for quality and technical support, BioAssay Systems is poised to capitalize on the ongoing shift toward high-throughput, data-driven research methodologies, effectively cementing its status as a cornerstone of modern life sciences innovation.

See full BioAssay Systems company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingProject Management
Business ServicesProject Management
Business ServicesHuman Resources Management Systems (HRMS)
Business ServicesCommercial Printing

Frequently Asked Questions Regarding BioAssay Systems Financial Insights

What are the most recent funding rounds that BioAssay Systems has completed, and what were the funding rounds?
BioAssay Systems has recently completed 2 funding rounds: Debt on Jan 28, 2021, Debt on May 3, 2020.
What is the total amount of funding BioAssay Systems has raised to date?
BioAssay Systems has raised a total of $359K in funding to date.
How many funding rounds has BioAssay Systems completed?
BioAssay Systems has completed 2 funding rounds.
How much funding did BioAssay Systems raise in its most recent funding round?
BioAssay Systems raised $209K in its most recent funding round.
Who are the lead investors in BioAssay Systems's latest funding round?
The lead investor in BioAssay Systems's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in BioAssay Systems's history?
The largest funding round in BioAssay Systems's history was $209K.
See more information about BioAssay Systems